Galmed Pharmaceuticals Ltd (GLMD)

Panoramica Notizia Cronologia dei prezzi Perché GLMD Giù? Forum Previsione Frazionamento azionario

Perché le azioni Galmed Pharmaceuticals Ltd (GLMD) sono in ribasso?

Abbiamo notato un calo di 6.15% nelle azioni di Galmed Pharmaceuticals Ltd (GLMD) durante la sessione di negoziazione di 2024-10-29. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!

2023-11-21:

Galmed Pharmaceuticals Ltd Stock (GLMD) dropped by 17.08% from $0.4343 to $0.3601 in the trading on Tuesday November 21, 2023. The reason why GLMD stock down today is due to the news of delay in sclerosing cholangitis Phase 2a study. Galmed Pharmaceuticals has recently made an announcement regarding the postponement of its highly anticipated Primary Sclerosing Cholangitis (PSC) Phase 2a study. Due to this unexpected delay, the commencement of the trial will be delayed by approximately six to nine months. This unforeseen setback has prompted Galmed Pharmaceuticals to reassess and adjust their plans accordingly.

GMAB

$22.32

1.11%

INCY

$74.12

0.26%

UTHR

$373.97

3.48%

MRNA

$54.36

0.66%

BGNE

$202.64

1.63%

BNTX

$113.10

0.74%

Galmed Pharmaceuticals Ltd (GLMD)

Perché le azioni Galmed Pharmaceuticals Ltd (GLMD) sono in ribasso?

Simile a GLMD